ArticleLeukemia2023

Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study.

N Gossai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.